Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1914148-54-1 | MDL No. : | MFCD29477768 |
Formula : | C11H17F3N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UNPHVIAXUMVJHN-UHFFFAOYSA-N |
M.W : | 282.26 | Pubchem ID : | 118705210 |
Synonyms : |
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.82 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 7.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 68.21 |
TPSA : | 78.43 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -9.15 cm/s |
Log Po/w (iLOGP) : | 1.49 |
Log Po/w (XLOGP3) : | -1.59 |
Log Po/w (WLOGP) : | 1.4 |
Log Po/w (MLOGP) : | 0.64 |
Log Po/w (SILICOS-IT) : | 1.53 |
Consensus Log Po/w : | 0.69 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.52 |
Solubility : | 84.8 mg/ml ; 0.3 mol/l |
Class : | Very soluble |
Log S (Ali) : | 0.45 |
Solubility : | 799.0 mg/ml ; 2.83 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | -2.35 |
Solubility : | 1.26 mg/ml ; 0.00446 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.89 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 126501-70-0 ]
1-(2,2,2-Trifluoroacetyl)piperidine-4-carboxylic acid
Similarity: 0.76
[ 700376-58-5 ]
(1R,3S,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate
Similarity: 0.74
[ 50632-83-2 ]
4-(2,2,2-Trifluoroacetamido)butanoic acid
Similarity: 0.72
[ 151038-94-7 ]
6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide 2,2,2-trifluoroacetate
Similarity: 0.69
[ 6258-28-2 ]
2-(2,6-Dioxopiperidin-4-yl)acetic acid
Similarity: 0.67
[ 126501-70-0 ]
1-(2,2,2-Trifluoroacetyl)piperidine-4-carboxylic acid
Similarity: 0.76
[ 151038-94-7 ]
6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide 2,2,2-trifluoroacetate
Similarity: 0.69
[ 6258-28-2 ]
2-(2,6-Dioxopiperidin-4-yl)acetic acid
Similarity: 0.67
[ 24537-50-6 ]
2-Oxopiperidine-4-carboxylic acid
Similarity: 0.65
[ 436099-97-7 ]
4-(Piperidin-4-yl)morpholine 2,2,2-trifluoroacetate
Similarity: 0.64
[ 126501-70-0 ]
1-(2,2,2-Trifluoroacetyl)piperidine-4-carboxylic acid
Similarity: 0.76
[ 6258-28-2 ]
2-(2,6-Dioxopiperidin-4-yl)acetic acid
Similarity: 0.67
[ 24537-50-6 ]
2-Oxopiperidine-4-carboxylic acid
Similarity: 0.65
[ 436099-97-7 ]
4-(Piperidin-4-yl)morpholine 2,2,2-trifluoroacetate
Similarity: 0.64
[ 53611-47-5 ]
4-(Hydroxymethyl)piperidin-2-one
Similarity: 0.64
[ 561314-57-6 ]
2,8-Diazaspiro[4.5]decan-3-one
Similarity: 0.62
[ 1075-89-4 ]
8-Azaspiro[4.5]decane-7,9-dione
Similarity: 0.62
[ 1588440-97-4 ]
2,6-Diazaspiro[3.4]octan-7-one oxalate
Similarity: 0.62
[ 1158750-89-0 ]
2,7-Diazaspiro[4.5]decan-3-one
Similarity: 0.60
[ 1147422-92-1 ]
2,7-Diazaspiro[3.5]nonan-1-one
Similarity: 0.59